Anti-JAG1/ AGS/ AGS1 monoclonal antibody

Anti-JAG1/ AGS/ AGS1 antibody for FACS & in-vivo assay

Target products collectionGo to JAG1/JAG1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0648-Ab-1/ GM-Tg-hg-MP0648-Ab-2Anti-Human JAG1 monoclonal antibodyHuman
GM-Tg-rg-MP0648-Ab-1/ GM-Tg-rg-MP0648-Ab-2Anti-Rat JAG1 monoclonal antibodyRat
GM-Tg-mg-MP0648-Ab-1/ GM-Tg-mg-MP0648-Ab-2Anti-Mouse JAG1 monoclonal antibodyMouse
GM-Tg-cynog-MP0648-Ab-1/ GM-Tg-cynog-MP0648-Ab-2Anti-Cynomolgus/ Rhesus macaque JAG1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0648-Ab-1/ GM-Tg-felg-MP0648-Ab-2Anti-Feline JAG1 monoclonal antibodyFeline
GM-Tg-cang-MP0648-Ab-1/ GM-Tg-cang-MP0648-Ab-2Anti-Canine JAG1 monoclonal antibodyCanine
GM-Tg-bovg-MP0648-Ab-1/ GM-Tg-bovg-MP0648-Ab-2Anti-Bovine JAG1 monoclonal antibodyBovine
GM-Tg-equg-MP0648-Ab-1/ GM-Tg-equg-MP0648-Ab-2Anti-Equine JAG1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0648-Ab-1/ GM-Tg-hg-MP0648-Ab-2; GM-Tg-rg-MP0648-Ab-1/ GM-Tg-rg-MP0648-Ab-2;
GM-Tg-mg-MP0648-Ab-1/ GM-Tg-mg-MP0648-Ab-2; GM-Tg-cynog-MP0648-Ab-1/ GM-Tg-cynog-MP0648-Ab-2;
GM-Tg-felg-MP0648-Ab-1/ GM-Tg-felg-MP0648-Ab-2; GM-Tg-cang-MP0648-Ab-1/ GM-Tg-cang-MP0648-Ab-2;
GM-Tg-bovg-MP0648-Ab-1/ GM-Tg-bovg-MP0648-Ab-2; GM-Tg-equg-MP0648-Ab-1/ GM-Tg-equg-MP0648-Ab-2
Products NameAnti-JAG1 monoclonal antibody
Formatmab
Target NameJAG1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-JAG1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species JAG1/ AGS/ AGS1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAD000003human JAG1 Adenovirus plasmid
    ORF Viral VectorvGMAD000003human JAG1 Adenovirus particle


    Target information

    Target IDGM-MP0648
    Target NameJAG1
    Gene ID182,16449,29146,718580,485769,101093427,783681,100064289
    Gene Symbol and SynonymsABE2,AGS,AGS1,AHD,AWS,CD339,CMT2HH,DCHE,Gena228,Gsfabe2,HJ1,Htu,JAG1,JAGL1,Ozz,Ser-1
    Uniprot AccessionP78504,Q63722
    Uniprot Entry NameJAG1_HUMAN,JAG1_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000101384
    Target ClassificationN/A

    The target: JAG1, gene name: JAG1, also named as AGS, AGS1, AHD, AWS, CD339, DCHE, HJ1, JAGL1. The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. [provided by RefSeq, Nov 2019].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.